tyrosine and semaxinib

tyrosine has been researched along with semaxinib in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (75.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kobayashi, S; Maru, Y; Nojima, Y; Sawano, A; Shibuya, M1
Bautch, VL; Johnson, JH; Kearney, JB; Kumar, R; Roberts, DM; Rosenberg, MP1
Chen, B; Larsen, SH; Li, CY; Sun, HB; Wang, SY; Xu, WX; Yang, RF; Yang, X; Yue, PB; Zhan, YQ; Zheng, H1
Hempel, C; Hoyer, N; Kurtzhals, JA; Staalsø, T1

Other Studies

4 other study(ies) available for tyrosine and semaxinib

ArticleYear
The c-Cbl/CD2AP complex regulates VEGF-induced endocytosis and degradation of Flt-1 (VEGFR-1).
    FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2004, Volume: 18, Issue:7

    Topics: 3T3 Cells; Adaptor Proteins, Vesicular Transport; Animals; Binding Sites; Cells, Cultured; Endocytosis; Endothelial Cells; Humans; Indoles; Liver; Macromolecular Substances; Mice; Phosphorylation; Protein Binding; Protein Processing, Post-Translational; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-cbl; Pyrroles; Rats; Recombinant Fusion Proteins; src Homology Domains; Tyrosine; Ubiquitin; Ubiquitin-Protein Ligases; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-1

2004
The vascular endothelial growth factor (VEGF) receptor Flt-1 (VEGFR-1) modulates Flk-1 (VEGFR-2) signaling during blood vessel formation.
    The American journal of pathology, 2004, Volume: 164, Issue:5

    Topics: Animals; Cell Differentiation; Cells, Cultured; Embryo, Mammalian; Indoles; Ligands; Mice; Mutation; Neovascularization, Physiologic; Phenotype; Phosphorylation; Pyrroles; Signal Transduction; Time Factors; Tyrosine; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-1; Vascular Endothelial Growth Factor Receptor-2

2004
SU5416 is a potent inhibitor of hepatocyte growth factor receptor (c-Met) and blocks HGF-induced invasiveness of human HepG2 hepatoma cells.
    Journal of hepatology, 2004, Volume: 41, Issue:2

    Topics: 3T3 Cells; Animals; Carcinoma, Hepatocellular; Cells, Cultured; DNA; Dose-Response Relationship, Drug; Endothelial Cells; Extracellular Signal-Regulated MAP Kinases; Fibroblasts; Gene Expression; Hepatocyte Growth Factor; Hepatocytes; Humans; Indoles; Liver Neoplasms; Mice; Neoplasm Invasiveness; Oncogene Proteins, Fusion; Phosphorylation; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-met; Pyrroles; Tyrosine

2004
Effects of the vascular endothelial growth factor receptor-2 (VEGFR-2) inhibitor SU5416 on in vitro cultures of Plasmodium falciparum.
    Malaria journal, 2014, May-28, Volume: 13

    Topics: Animals; Antimalarials; Cytosol; Disease Models, Animal; Erythrocytes; Female; Flow Cytometry; Humans; Immunohistochemistry; Indoles; Malaria; Mice, Inbred C57BL; Plasmodium berghei; Plasmodium falciparum; Pyrroles; Tyrosine; Vascular Endothelial Growth Factor Receptor-2

2014